Sign In
Sign Out
My Account
Subscribe
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
Special reports
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 12, 2005
View Archived Issues
New phase IIb study for CS-917 in type 2 diabetes
Read More
Japanese phase II study of BAY-43-9006 for advanced renal cell carcinoma
Read More
Valeant submits complete response for Zelapar
Read More
PA-457 awarded fast track status for HIV
Read More
Fast track designation for epratuzumab in lupus
Read More
Approvable letter for Bonefos for adjuvant treatment of breast cancer
Read More
Sirna launches programs to treat asthma and diabetes with RNAi technology
Read More
VX-680 enters phase I study in solid tumor patients
Read More
IND submission for HCV-796
Read More
Peplin reports positive phase I results for PEP-005 Topical
Read More
Priority review for Aceon sNDA
Read More
New phase III trial evaluates Velcade in newly diagnosed multiple myeloma
Read More
Dosing completed in phase II study of Puricase for severe gout
Read More
Human Genome Sciences cleared for phase I study of CCR5 mAb for HIV
Read More
Sangamo submits IND for SB-509 to treat diabetic neuropathy
Read More
Treatment phase begins in SHEPHERD study of eculizumab for PNH
Read More
gamma-Tocopherol, a vitamin E form, is effective against prostate cancer
Read More
Therapeutic vaccine protects against HIV-induced autoimmunity
Read More
HCV NS3-NS4A protease inhibitor and INF-alpha synergistically inhibit HCV replication in vitro
Read More
Azithromycin improves coronary microcirculation in CAD patients
Read More
Low menaquinone levels related to coronary heart disease
Read More
Thiazolidinedione derivatives claimed by Incyte
Read More
Ono discloses a series of CCR5 receptor antagonists
Read More
Akt inhibitors prepared and tested at Lilly
Read More
Kalypsys patent covers novel PPAR modulators for obesity, diabetes, etc.
Read More
Tachykinin NK2 antagonists in early development at Menarini
Read More
Scientists at Enanta report novel agents for hepatitis C infections
Read More
Muscarinic M1 receptor antagonists emerge from research at Lilly
Read More
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe